One of the out-patient rehabilitation options for individuals in Elkton who are battling with opioid dependence and addiction is called opioid maintenance therapy. Licensed clinics and doctors are authorized to give certain medications to opioid addicted people, many that are opioids also and are habit forming. With low amounts the client does not feel high and also does not experience intense cravings and isn't in opioid withdrawal. Methadone is the first medication tried for this sole purpose, but there are a few more choices currently to pick from.
Methadone is an opiate and is meant to be taken at an outpatient clinic certified to administer the med, that is taken daily as a pill or liquid. The price of the med is around $150 monthly. Buprenorphine is also an opiate based med, and is a pill often taken one day on, one day off. But different from Methadone that is only be administered in highly structured clinics, Buprenorphine can be prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is around three hundred dollars monthly for the generic of the med. There is also a version of buprenorphine containing the drug naloxone, which is a med which reverses the effects of opioids. An individual taking this formulation, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It too is taken every day, and costs approximately $450 a month. Naltrexone is another drug used in opioid maintenance therapy, but unlike the other drugs aforementioned it's an opioid blocker and is not an opiate. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents an individual from experience being high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 /month.
There are 4 Alcohol and Drug Treatment Programs offering this service in Elkton, MD
For All Alcohol and Drug Rehabilitation Programs In Elkton, Click Here.